A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?
Cancerworld published an article, "A silver lining: Could changes forced by the pandemic point to better ways to conduct our clinical trials?" on 28 October 2020. To read the full article and Prof. Jaap Verweij's comment, click the following link:...
Oncology Meeting: EORTC – IBCD 2020 (23 October 2020)
IBCD 2020 will explore routes through the continually evolving scientific, methodological and regulatory environment for drug and biomarker development. The EORTC, NCI, EMA, and AACR will will work alongside FDA and PMDA specialists to build upon recommendations and...
NEW EU STRATEGY: Pharmaceutical Strategy – Timely patient access to affordable medicines
The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry. It will address: the life cycle of medicines from R&D to authorisation and patient access...
ESMO provides first recommendations on use of next-generation sequencing in metastatic cancer
Cancerworld has published an article, "ESMO provides first recommendations on use of next generation sequencing in metastatic cancer." To read the full article and Prof. Ruth Plummer's comment on the ESMO publication, click the following link:...
CDDF announces new leadership – 22 June 2020
CDDF is excited to announce newly elected board members and officers appointed at its first General Assembly since its establishment as a non-profit association in Belgium that took place on 9 June 2020. The CDDF wishes to thank its outgoing board members, Prof. Leif...
CDDF & EORTC announces new collaboration
European Organisation for Research and Treatment of Cancer (EORTC) and Cancer Drug Development Forum (CDDF) announce their new collaboration on series of clinical cancer research related workshops covering all aspect from early dug...